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Purpose: The carcinoid tumor was recently categorized as a malignant disease due to its possibility of metastasis. This 
study was aimed to investigate the clinical characteristics and the metastatic rate of colorectal carcinoid tumors.
Methods: Charts were reviewed for 502 patients diagnosed with and treated for colorectal carcinoid tumors between Janu-
ary 2006 and December 2009. The location, size, depth and metastatic status of the tumors were collected.
Results: Including 24 synchronous tumors from 12 patients, 514 carcinoid tumors were removed. Most of them were found 
in the rectum (97.3%). The male-to-female ratio was 1.38 to 1, and mean age was 50.2 ± 11.4 years. The mean tumor size 
was 5.8 ± 3.6 mm. Less than 10-mm-sized tumors had a 1.95% lymph node metastatic rate; tumors with sizes from 10 mm 
to 20 mm and larger than 20 mm had 23.5% and 50% lymph node metastatic rates, respectively. Two cases had distant me-
tastasis; one with a 22-mm-sized tumor metastasized to the liver, and the other with a 20-mm-sized tumor metastasized 
to the peritoneum. Among 414 patients who completed metastatic studies, 93.8% were classified as stage I, 0.9% as stage 
II, 4.8% as stage III and 0.5% as stage IV. 
Conclusion: Colorectal carcinoid tumors smaller than 10 mm have a low rate of lymph node metastasis, but those sized 10 
mm or larger incur significant risk. Further investigation regarding additional risk factors should be done to develop 
proper treatment guidelines for these tumors. 
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able rates of lymph node metastasis in carcinoid tumors. As well, 
the American Joint Council on Cancer (AJCC) has classified 
carcinoid tumors as malignant tumors [5].
The incidence of colorectal carcinoid tumors in Korea may be 
on the rise as the degree of screening colonoscopy increases [6, 
7]. Although there have been reports of small-sized carcinoid 
tumors with lymph node metastasis, it is very difficult to assess 
national prevalence and rates of metastasis because previous 
domestic studies were limited to a single institute and had a lim-
ited volume of patients. Thus, the aim of this study is to investi-
gate clinical characteristics focusing on the metastatic rate of 
colorectal carcinoid tumors through a large scale study.
METHODS
The colonoscopy study group of the Korean Society of Colo-
proctology conducted a retrospective study of colorectal carci-
noid tumors in collaboration with eight institutes from January 
2006 to December 2009. We gathered data such as age, gender, 
site, size, invasion depth and the presence of metastasis through 
the collection and review of medical records.
Rectal carcinoids were defined as tumors located within 15 cm 
INTRODUCTION
Carcinoid tumors are the most common neuroendocrine tumor 
in the gastrointestinal system. The incidence of carcinoid tumors 
varies depending on the organ. However, the rectum and the il-
eum are the most prevalent tumor sites in the gastrointestinal 
system [1].
Among gastrointestinal carcinoid tumors, colonic carcinoids 
have been reported to be relatively rare while rectal carcinoid 
tumors have been reported to be the most prevalent [1-4]. Gen-
erally, carcinoid tumors have been recognized as having low ma-
lignant potential. However, recent studies have shown consider-
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of the anal verge while tumors more than 15 cm above the anal 
verge were regarded as colonic carcinoids. The tumors were clas-
sified into three groups according to tumor size: 1) a tumor di-
ameter less than 10 mm, 2) a 10-mm to 20-mm tumor diame-
ter, and 3) a diameter larger than 20 mm. Tumor sizes were con-
firmed through pathology reports. In the case of tumor sizes not 
being clearly described in the pathology reports, the size was 
determined according to the colonoscopy reports. Treatment 
methods were classified as endoscopic resection, transanal re-
section and radical operation.
In cases treated by radical operation, the presence of lymph 
node metastasis was determined by using a pathology report 
while in cases treated by local resection, including colonoscopic 
removal, metastatic status were assessed by radiologic studies 
(computer tomography [CT] scan). Cases which did not un-
dergo metastatic work ups were excluded from the analysis of 
lymph node metastasis. If there were synchronous carcinoid 
tumors, only the largest tumors were included in the analysis of 
lymph node metastasis.
The tumor disease stages were determined according to the 
AJCC Cancer Staging 7th edition, revised in 2010. Statistical 
analysis was done with the Fisher’s exact test and a P-value less 
than 0.05 was considered to be statistically significant.
RESULTS
Five hundred two patients were treated for carcinoid tumors dur-
ing the study period. In 12 patients, two carcinoid tumors were 
detected simultaneously (synchronous carcinoid tumor, 2.4%); 
thus, the total number of resected carcinoid tumors was 514. 
Fourteen carcinoid tumors were found in the colon, which ac-
counts for 2.7%, and 500 carcinoid tumors (97.3%) were detected 
in the rectum. The ratio between males and females was 1.38:1, 
and the mean patient age was 50.2 years. The average tumor size 
was 5.8 mm, and a regional resection, including colonoscopic 
treatments, was performed in 473 cases (92%) (Table 1).
The result of pathological tests for 39 cases treated by radical 
surgery showed 18 cases of lymph node metastasis (46.2%). The 
relationship of lymph node metastasis to tumor size for tumors 
smaller than 10 mm was 23.5%, for tumors between 10 mm and 
20 mm, it was 63.2%, and for tumors larger than 20 mm, it was 
was 66.7% (Table 2).
Metastasis was assessed through CT scans or pathological ex-
aminations in 414 cases. When cases showing metastasis find-
ings on the test were considered as positive for lymph node me-





  Colon  
  (n = 14)
Gender
a      
   Male 290 (57.8) 281 (57.6)   9 (64.3)
   Female 212 (42.2) 207 (42.4)   5 (35.7)
Age
a 50.2 ± 11.4 50.0 ± 11.3 55.1 ± 14.2
Size 5.8 ± 3.6 5.7 ± 3.5 7.6 ± 5.2
Treatment    
   Endoscopic resection 419 (81.5) 408 (81.6) 11 (78.6)
   Local resection   54 (10.5)   54 (10.8) 0 (0.0)
   Radical operation 41 (8.0) 38 (7.6)   3 (21.4)
Values are presented as number (%) or mean ± SD. 
aTotal number of patients is 502.
Table 2. Rate of lymph node metastasis in patients who underwent 
radical surgery
Tumor size (mm)
  Total  






<10    4/17 (23.5)   4/17 (23.5) -
10-20  12/19 (63.2) 11/16 (68.8) 1/3 (33.3)
>20      2/3 (66.7)     2/3 (66.7) -
Total 18/39 (46.2) 17/36 (47.2) 1/3 (33.3)
The values in parentheses are presented as percent.
aTwo synchronous tumors in two patients (total number of carcinoid tumors is 41).
Table 3. Rate of lymph node metastasis in 414 colorectal carcinoisa
Tumor size (mm)
   Total  
   (n = 414)
 Rectum  
 (n = 402)
 Colon  
 (n = 12)
<10     7/359 (1.95)     7/352 (1.99) 0/7
10-20     12/51 (23.5)     11/46 (23.9)     1/5 (20.0)
>20         2/4 (50.0)         2/4 (50.0) -
Total 21/414 (5.1) 20/402 (5.0) 1/12 (8.3)
The values in parentheses are presented as percent.
aCases of radical operation or metastasis-evaluation using CT scan.
Table 4. Tumor-node-metastasis (TNM) staging of colorectal carci-
noid tumors according to American Joint Council on Cancer, 7th 
edition (n = 414)
TNM stage (clinical or pathologic)  No. (%)
I T1aN0M0  353 (85.3)
T1bN0M0  35 (8.5)
IIa T2N0M0    4 (0.9)
IIb T3N0M0    0 (0.0)
IIIa T4N0M0    0 (0.0)
IIIb Any T, N1M0  20 (4.8)
IV Any T, Any N, M1    2 (0.5)
T1, tumor invades lamina propria or submucosa and size ≤ 2 cm; T1a, tumor size 
< 1 cm in greatest dimension; T1b, tumor size 1 to 2 cm in greatest dimension; 
T2, tumor invades muscularis propria or size > 2 cm with invasion of lamina pro-
pria or submucosa; T3, tumor invades through the muscularis propria into the sub-
serosa, or into non-peritonealized pericolic or perirectal tissues; T4, tumor invades 
peritoneum or other organs; N0, no regional lymph node metastasis; N1, regional 
lymph node metastasis; M0, no distant metastasis; M1, distant metastasis.Journal of The Korean Society of
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tastasis, the aforementioned incidence according to tumor size 
for tumors smaller than 10 mm was 1.95% while for sizes be-
tween 10 mm and 20 mm, it was 23.5%, and for sizes larger than 
20 mm, it was 50.0%. As tumor sizes increased, the metastasis 
incidence also increased (Table 3), and the frequency of lymph 
node metastasis in cases with carcinoid tumors smaller than 10 
mm was confirmed to be significantly lower than in other groups 
(P < 0.001). Regarding two cases with distant metastasis, one 
rectal case had metastasis to the liver, and the other colonic case 
involved peritoneal metastasis. The result of the TNM disease stage 
classification according to the AJCC is shown in Table 4.
DISCUSSION 
Generally, the incidence of carcinoid tumors of the colon has 
been reported to be very low and comprises 4-8% of carcinoid 
tumors in the digestive system [1-4]. Colonic carcinoid tumors 
are detected in the cecum primarily, and two-thirds of colonic 
carcinoid tumors have been reported to occur in the right side 
of the colon [8]. More than half of carcinoid tumors of the colon 
are associated with lymph node metastasis or distant metastasis 
at the time of detection. Thus, prognosis is poor, with 5-year sur-
vival rates reported to be approximately 40-70% [1, 9].
In our study, although it was limited to the colon and the rec-
tum, the tumor incidence in the colon was 2.7%, which is lower 
than the generally accepted incidence rate. As well, the number 
of cases treated with radical surgery was only three. Among the 
three, one case had lymph node metastasis, and another case 
had peritoneal metastasis. For the remaining eleven cases, the 
tumors were resected locally through colonoscopy. Using these 
data, estimating the lymph node metastasis rate in terms of co-
lonic carcinoid tumors is very difficult, making risk predictions 
infeasible.
The proportion of colonoscopic resections for colonic carci-
noid tumors in our series was relatively high in relation to gen-
eral treatment guidelines, which recommend radical surgery 
for all colonic carcinoids. A possible explanation for this is that 
contrary to the usual experience of finding colonic carcinoid 
tumors at advanced stages, many colonic tumors in our series 
may were found incidentally at smaller sizes during diagnosis, 
deeming colonoscopic resection appropriate.
Most carcinoid tumors we detected were in the rectum, corre-
lating with known findings as to the organ in which carcinoid 
tumors are detected most frequently. In our study, cases involv-
ing rectal carcinoid tumors totaled 500, accounting for approxi-
mately 97.3%, with an average size of 5.7 mm. The frequency of 
lymph node metastasis for rectal carcinoid tumors was found 
to be 5.0%. Most rectal carcinoid tumors were treated by endo-
scopic or regional resection, such as transanal resection.
To evaluate the risk of metastasis, pathological examination of 
lymph nodes should be implemented. However, small rectal car-
cinoids are known to have little risk of metastasis, making local 
treatment desirable and reserving radical surgery for selected 
cases with risk factors associated with lymph node metastasis. 
Therefore, we substituted radiologic evaluation with CT scans 
for pathologic examination to confirm lymph node metastasis. 
Although CT scans do not reflect lymph node metastasis as ac-
curately as a pathologic examination, if no sign of metastasis ap-
pears in the CT scan, we regard the case as negative for lymph 
node metastasis.
Four hundred four cases undergoing radical surgery and/or 
CT scan were included in the evaluation of metastasis. There 
was a direct correlation between tumor size and lymph node 
metastasis. The lymph node metastasis rate was approximately 
2% if the tumor size was less than 10 mm and increased gradu-
ally up to 50% as the tumor size increased to larger than 20 mm. 
For tumor sizes between 10 mm and 20 mm, the risk of lymph 
node metastasis was as high as 24%, which was similar to the 
results reported by Soga et al. [2]. This is thought to be a very 
important finding in deciding treatment modality. A consensus 
exists for which treatment method is appropriate for rectal car-
cinoid tumors with sizes between 10 mm and 20 mm.
Carcinoid tumors develop in the mucosal gland and gradually 
infiltrate to the lamina propria, submucosal layer and deeper 
layer of the bowel wall. As the disease stage advances, carcinoid 
tumors may be accompanied by lymph node or distant metas-
tasis. These clinical behaviors are the characteristics of malignant 
neoplasms. Thus, it is reasonable to regard colorectal carcinoids 
as malignant tumors. In diverse reports, lymph node metastasis 
and distant metastasis were reported and are thought to be tu-
mors with a malignant potential comparable to that of an ade-
nocarcinoma [2, 3]. In the recently revised AJCC cancer stag-
ing, carcinoid tumors are classified as a malignant disease. The 
stage classifications are based on the size of the tumor, the in-
volved layer of the bowel wall and the presence or absence of 
lymph node or distant metastasis. According to this staging sys-
tem, our series of cases are classified into 388 stage I cases, 4 
stage IIA cases, no stage IIB or IIIA cases, 20 stage IIIB cases, 
and 2 stage IV cases. The staging results reflect that most cases 
were early lesions and were detected incidentally by screening 
colonoscopy.
In cases of rectal carcinoids, the risks of lymph node metastasis 
and distant metastasis vary depending on the tumor size, mak-
ing tumor size the most important factor in deciding on a treat-
ment method. The reported risk of lymph node metastasis for 
rectal carcinoids smaller than 10 mm is usually less than 3%; 
thus, regional treatment including colonoscopic resection is ap-
propriate. However, radical surgery is recommended for tumors 
larger than 20 mm, where the risk of metastasis is known to be 
60-80%. Treatment methods for tumors with sizes between 10 
mm and 20 mm are controversial, and no established treatment 
guideline exists.
Known risk factors, other than tumor size, are tumor invasion 
beyond the proper muscle, the degree of cell differentiation and Journal of The Korean Society of
Coloproctology
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the mitotic rate. A population-based study in Japan reported 
3.7% lymph node metastasis for rectal carcinoids with sizes of   
5 mm and less and 10% for tumors with sizes less than 10 mm 
[2]. These results complicate deciding on treatment methods 
even in small-sized rectal carcinoids. Therefore, if lymph node 
metastasis is to be predicted accurately, additional studies on 
risk factors are required, and treatment methods should be de-
termined considering various risk factors [9-11].
The large number of cases involved in this study aided in re-
vealing meaningful data in terms of the risk of lymph node me-
tastasis, yet, some limitations should be mentioned. First, it was 
a retrospective cross-sectional study and collected data were re-
stricted to findings when tumors were detected and treated. Sec-
ond, there may have been selection bias. In some institutions, 
only cases involving radical surgery were included. These cases 
may have had risk factors associated with lymph node metasta-
sis. Third, we could not estimate the overall incidence, and this 
study lacked long-term follow-up results in terms of recurrence. 
This may play a role in underestimating the risk of lymph node 
metastasis. Additional studies on recurrence and the rate of me-
tastasis through long-term follow-up are required in the future.
In rectal carcinoid tumors, the size of the tumor is directly re-
lated to the frequency of lymph node metastasis. In carcinoid 
tumors with sizes smaller than 10 mm, the risk of lymph node 
metastasis was low; thus, it could be treated by regional treat-
ments including colonoscopic resection. However, in carcinoid 
tumors with sizes larger than 10 mm, the risk of lymph node 
metastasis increased remarkably. Especially, rectal carcinoid tu-
mors with sizes between 10 mm and 20 mm showed a lymph 
node metastasis rate of 23.5%, requiring treatment to be deter-
mined by considering various risk factors. Additional studies 
on the risk factors for lymph node metastasis are needed.
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